Please assess the completion status of the following clinical trial:

Trial Title: Role of Glutamine as Myocardial Protector in Elective On-Pump CABG Surgery With Low EF

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients with coronary heart disease indicated for elective coronary artery bypass grafting under cardiopulmonary bypass~* Patients with left ventricle ejection fraction 31% -50% confirmed by echocardiography or radio nuclear study.~* Patients age ≥18 years~* Never had heart surgery before~* Agree to participate in the study and signed informed consent~Exclusion Criteria:~* Emergency coronary artery grafting bypass~* Having additional procedures other than coronary artery bypass grafting~* History of myocardial infarction with onset less than 3 months~* Patients with serum creatinine level more than 2 g/dL~* Patients with ALT/AST levels more than 1.5 times the upper limit of normal value~* Required to use intra-aortic balloon pump pre-operatively~* History of stroke with onset less than 3 months~* History of pre-operative atrial fibrillation~* History of heart conduction problem and/or using a pacemaker~* Patients with HIV~* Contraindications to pulmonary artery catheter insertion~Drop out Criteria~* Experiencing stroke after surgery~* Experiencing surgery related complication (haemorrhage) requiring re operation~* Requiring continuous veno-venous hemofiltration or haemodialysis after surgery~* Delayed sternal closure~* Aortic cross clamp duration more than 120 minutes and/or cardiopulmonary bypass time more than 180 minutes

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Glutamine (Type: EXPERIMENTAL): Intravenous L-alanyl-L-glutamine 0.5 mg/kgbw
- Control (Type: PLACEBO_COMPARATOR): Intravenous NaCl 0.9%

Based on this trial design, predict the completion outcome and termination type (if applicable).